Gene: PLEKHM3
Official Full Name: pleckstrin homology domain containing M3provided by HGNC
Gene Summary: Predicted to enable metal ion binding activity. Predicted to be involved in myoblast differentiation. Predicted to be located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15037 | PLEKHM3 Knockout cell line (HeLa) | Human | PLEKHM3 | 1:3~1:6 | Negative | Online Inquiry |
KO15038 | PLEKHM3 Knockout cell line (HCT 116) | Human | PLEKHM3 | 1:2~1:4 | Negative | Online Inquiry |
KO15039 | PLEKHM3 Knockout cell line (HEK293) | Human | PLEKHM3 | 1:3~1:6 | Negative | Online Inquiry |
KO15040 | PLEKHM3 Knockout cell line (A549) | Human | PLEKHM3 | 1:3~1:4 | Negative | Online Inquiry |
PLEKHM3 Gene Knockout Cell Lines are specifically engineered cellular systems that lack the PLEKHM3 gene, which encodes a protein involved in various cellular processes including vesicular trafficking and immune responses. Utilizing CRISPR-Cas9 technology, these cell lines provide a powerful tool for researchers to study the functional implications of PLEKHM3 deficiency in cellular and physiological contexts. By eliminating the expression of this gene, scientists can observe alterations in cellular behavior, signaling pathways, and responses to external stimuli.
The primary mechanism of these knockout cell lines involves the precise editing of the genomic DNA, which disrupts the PLEKHM3 gene and consequently eliminates its protein product. This allows for the exploration of its role in diverse biological processes such as autophagy, inflammation, and potentially cancer progression, making these cell lines crucial for translational research endeavors. The absence of PLEKHM3 further permits the investigation of compensatory pathways and interactions with other cellular components, providing deeper insights into the molecular underpinnings of various diseases.
In scientific and clinical research settings, the value of PLEKHM3 Gene Knockout Cell Lines extends beyond basic research; they have applications in drug discovery, disease modeling, and the development of targeted therapies. Researchers looking to delineate the molecular mechanisms of diseases linked to PLEKHM3 can utilize these cell lines to validate hypotheses and assess therapeutic interventions.
Compared to alternative models such as siRNA-mediated knockdown, these knockout cell lines offer a more permanent mutation that allows for the sustained analysis of PLEKHM3's role over time. This stability improves experimental reproducibility and decreases variability across experiments, leading to more robust and reliable data.
As a leader in biological research solutions, our company specializes in providing high-quality gene knockout models that empower researchers and clinicians alike. With a commitment to innovation and excellence, we ensure that our products meet the highest standards of scientific rigor, thereby supporting advancements in the understanding and treatment of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.